So, Adagrasib is this new kind of inhibitor that’s supposed to zero in on these KRAS G12C mutations. These mutations are a big deal in lung cancer, especially the non-small cell type. The tablets are 200 mg each.
You’re supposed to take 600 mg, twice a day, no matter if you’ve eaten or not. Each bottle has 180 of these tablets. And remember, you need to take them with a healthcare pro watching over you.
